Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 5/2005

01-10-2005 | ORIGINAL ARTICLE

Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

Authors: Yasunori Yaegashi, Kamon Shirakawa, Nobuhiro Sato, Yasushi Suzuki, Masahiro Kojika, Satoko Imai, Gaku Takahashi, Michiko Miyata, Shoji Furusako, Shigeatsu Endo

Published in: Journal of Infection and Chemotherapy | Issue 5/2005

Login to get access
Metadata
Title
Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis
Authors
Yasunori Yaegashi
Kamon Shirakawa
Nobuhiro Sato
Yasushi Suzuki
Masahiro Kojika
Satoko Imai
Gaku Takahashi
Michiko Miyata
Shoji Furusako
Shigeatsu Endo
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 5/2005
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-005-0400-4

Other articles of this Issue 5/2005

Journal of Infection and Chemotherapy 5/2005 Go to the issue

NOTE

In vitro activity of β-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics

ORIGINAL ARTICLE

Presence of a mutation in ponA1 of Neisseria gonorrhoeae in numerous clinical samples resistant to various β-lactams and other, structurally unrelated, antimicrobials

NOTE

Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan

NOTE

Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases

ORIGINAL ARTICLE

Surgical antimicrobial prophylaxis in transurethral ureterolithotripsy

REVIEW ARTICLE

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits